Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Exp Clin Psychopharmacol. 2015 Oct 12;23(6):415–421. doi: 10.1037/pha0000053

Table 4.

Severity of Symptoms Among Individuals Who Endorsed Them.

Mean (±SD) severity of Withdrawal Discomfort Scale (WDS) symptoms that were reported, and mean severity scores on individual symptoms among women (n=45) and men (n=91). Scores were compared between women and men using t-tests. Significant (p < 0.05) sex differences are highlighted with bold text.

Women Men p-value
mean severity of any WDS symptoms reported 1.81 (.05) 1.66 (0.5) 0.10
depressed mood 1.5 (0.7) 1.5 (0.6) 0.75
irritability 1.9 (0.7) 1.7 (0.7) 0.21
nervousness/anxiety 1.9 (0.8) 1.5 (0.7) 0.04
restlessness 2.2 (0.8) 1.8 (0.7) 0.02
increased aggression 2.0 (0.8) 1.6 (0.7) 0.05
increased anger 1.9 (0.7) 1.6 (0.7) 0.06
violent outbursts 1.5 (0.7) 1.6 (0.8) 0.74
nausea 1.6 (0.9) 1.3 (0.5) 0.56
decreased appetite 2.2 (0.8) 1.9 (0.7) 0.11
stomach pain 1.2 (0.4) 1.0 (0.0) 0.17
shakiness 1.3 (0.5) 1.1 (0.3) 0.18
sweating 1.7 (0.5) 1.4 (0.7) 0.17
sleep difficulty 2.3 (0.7) 2.2 (0.7) 0.46
strange/wild dreams 1.5 (0.7) 1.6 (0.7) 0.66
craving to smoke cannabis * 2.3 (0.7) 2.3 (0.8) 0.63

Note. WDS = 14-item Withdrawal Discomfort Scale. Severity scores range from 1 (mild) to 3 (severe).

*

Craving is reported separately as it is not one of the symptoms included in the WDS total score.

HHS Vulnerability Disclosure